Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data

Table 2 Vaccine coverage of survey respondents

Parameters	Parents of IBD patients (n = 51)	Parents of JIA patients (n = 81)	Parents of HC (n = 58)	P value
Vaccine status
Completed vaccination according to the national calendar, n (%)	42 (82.3)	65 (79.9)	52 (91.4)	0.320
Temporary medical contraindications for vaccination (postponed vaccination), n (%)	9 (17.6)	14 (17.3)	2 (3.4)	0.000001
Refused to be vaccinated, n (%)	0 (0)	2 (2.5)	3 (5.2)	0.00001
Vaccine-associated reactions: No reaction Fever Injection site reactions	38 (74.5) 11 (21.6) 2 (3.9)	41 (50.6) 27 (33.3) 13 (16.1)	31 (53.5) 14 (24.1) 13 (22.4)	0.020
Continued vaccination after diagnosis, n (%)	5 (10.9)	6 (7.4)	NA	0.505
Had an opportunity to discuss vaccinations with the attending physician, n (%)	16 (32)	23 (28.4)	NA	0.716
Control of anti-vaccine antibodies before immunosuppressive treatment, n (%)	22 (43.2)	24 (29.6)	NA	0.147
Factors encouraged vaccination, n (%) - Personal beliefs - Doctor's advice - Internet / Media - Parents' forums - Others	10 (20) 42 (84) 2 (4) 2 (4) 2 (4)	25 (30.8) 56 (69.1) 8 (9.9) 9.9 (12.3) 5 (6.4)	40 (70.9) 19 (34.5) 7 (12.7) 1 (1.8) 6 (10.9)	0.010
Additional vaccines, n (%), against - tick-borne encephalitis - influenza - meningococcus - pneumococcus - varicella	8 (9.8) 6 (11.7) 8 (16.0) 29 (56.8) 6 (12.7)	3 (3.7) 9 (11.1) 8 (9.8) 23 (29.4) 7 (6,2)	8 (14.5) 20 (35.1) 21 (36.8) 27 (48.9) 17 (30.2)	0.003 0.002 0.0000001 0.000004 0.000002

IBD: Inflammatory bowel disease; JIA: Juvenile Idiopathic Arthritis; HC: Healthy children.